Viloshini Krishna Manickum, Lehlohonolo John Mathibe
{"title":"南非夸祖鲁-纳塔尔省私立和公立医疗机构中 COVID-19 疫苗的浪费情况","authors":"Viloshini Krishna Manickum, Lehlohonolo John Mathibe","doi":"10.1093/inthealth/ihae056","DOIUrl":null,"url":null,"abstract":"Background In KwaZulu-Natal (KZN), South Africa, COVID-19 vaccinations commenced in May 2021. This study investigated the extent and reasons for COVID-19 vaccine (C19V) wastage in KZN and strategies undertaken to mitigate loss. Methods This two-phase multicenter study was conducted at private and public healthcare facilities from May 2021 to July 2022. Results KZN reported 2% Pfizer and 1% Janssen C19V wasted, mainly due to expiry. C19V waste-minimization strategies reported by 100% public and private sector vaccination leads included cold chain monitoring, designated trained staff and the use of stock-management systems. Conclusions The WHO’s risk-mitigation factors should be implemented continuously to minimize vaccine wastage.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 vaccine wastage in private and public healthcare facilities in KwaZulu-Natal, South Africa\",\"authors\":\"Viloshini Krishna Manickum, Lehlohonolo John Mathibe\",\"doi\":\"10.1093/inthealth/ihae056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background In KwaZulu-Natal (KZN), South Africa, COVID-19 vaccinations commenced in May 2021. This study investigated the extent and reasons for COVID-19 vaccine (C19V) wastage in KZN and strategies undertaken to mitigate loss. Methods This two-phase multicenter study was conducted at private and public healthcare facilities from May 2021 to July 2022. Results KZN reported 2% Pfizer and 1% Janssen C19V wasted, mainly due to expiry. C19V waste-minimization strategies reported by 100% public and private sector vaccination leads included cold chain monitoring, designated trained staff and the use of stock-management systems. Conclusions The WHO’s risk-mitigation factors should be implemented continuously to minimize vaccine wastage.\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/inthealth/ihae056\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/inthealth/ihae056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
COVID-19 vaccine wastage in private and public healthcare facilities in KwaZulu-Natal, South Africa
Background In KwaZulu-Natal (KZN), South Africa, COVID-19 vaccinations commenced in May 2021. This study investigated the extent and reasons for COVID-19 vaccine (C19V) wastage in KZN and strategies undertaken to mitigate loss. Methods This two-phase multicenter study was conducted at private and public healthcare facilities from May 2021 to July 2022. Results KZN reported 2% Pfizer and 1% Janssen C19V wasted, mainly due to expiry. C19V waste-minimization strategies reported by 100% public and private sector vaccination leads included cold chain monitoring, designated trained staff and the use of stock-management systems. Conclusions The WHO’s risk-mitigation factors should be implemented continuously to minimize vaccine wastage.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
